Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 45 (HNRNPA1P45)

Target
HNRNPA1P45
Molecular classification
Other (Pseudogene)
01

Overview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 45 (HNRNPA1P45) is a pseudogene—a non-functional copy derived from the HNRNPA1 gene—that does not encode a functional protein. Pseudogenes such as HNRNPA1P45 generally lack therapeutic relevance because they are not expressed as active proteins and lack enzyme, receptor, or transporter functions. While some pseudogenes can have regulatory roles (for example, acting as competitive endogenous RNAs), the specific function or involvement of HNRNPA1P45 in any biological process or pathology has not been established in the available literature. Therefore, it is not a drug target, biomarker, or disease gene in its own right, nor is it linked to any specific safety or therapeutic concerns. Note: You may be seeking information on HNRNPA1 (the functional gene) or another active heterogeneous nuclear ribonucleoprotein, which are well-characterized RNA-binding proteins implicated in RNA processing, telomere function, and multiple diseases; HNRNPA1P45 does not share these functional attributes and is instead categorized as a non-coding, non-functional pseudogene.

Other names
HNRNPA1P45
02

Biological functions

Other (no direct function; pseudogene—does not encode functional protein)
03

Disease associations

Other (no direct role reported; pseudogenic variants may be associated with cancer transcriptomes broadly, but not directly for HNRNPA1P45)

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 45 (HNRNPA1P45).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 45 (HNRNPA1P45).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call